(Q51760389)

11 April 2018

title

New verticilides, inhibitors of acyl-CoA:cholesterol acyltransferase, produced by Verticillium sp. FKI-2679. (English)

1 reference

11 April 2018

1 reference

1 reference

1 reference

1 reference

1 reference

Taichi Ohshiro

1

1 reference

11 April 2018

Daisuke Matsuda

2

1 reference

11 April 2018

Takeuchi Kazuhiro

3

1 reference

11 April 2018

Ryuji Uchida

4

1 reference

11 April 2018

Kenichi Nonaka

5

1 reference

11 April 2018

Rokuro Masuma

6

1 reference

11 April 2018

Hiroshi Tomoda

7

1 reference

11 April 2018

publication date

14 March 2012

1 reference

11 April 2018

full work available at URL

https://www.nature.com/articles/ja201212.pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1038/ja.2012.12?email=unpaywall_01@example.com

published in

The Journal of Antibiotics

1 reference

11 April 2018

volume

65

1 reference

11 April 2018

issue

5

1 reference

11 April 2018

page(s)

255-262

1 reference

11 April 2018

https://api.unpaywall.org/v2/10.1038/ja.2012.12?email=unpaywall_01@example.com

1 reference

19 March 2024

access restriction status

open access

1 reference

inferred from online access status

exact match

https://scigraph.springernature.com/pub.10.1038/ja.2012.12

0 references

cites work

Inhibitors of acyl-coenzyme a: cholesterol acyltransferase

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase. Its cloning, expression, and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

Characterization of two human genes encoding acyl coenzyme A:cholesterol acyltransferase-related enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: individual ACAT uniqueness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

Selectivity of microbial acyl-CoA: cholesterol acyltransferase inhibitors toward isozymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

Selective inhibition of acyl-CoA:cholesterol acyltransferase 2 isozyme by flavasperone and sterigmatocystin from Aspergillus species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

Isoform-specific inhibitors of ACATs: recent advances and promising developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

Verticilide, a new ryanodine-binding inhibitor, produced by Verticillium sp. FKI-1033.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

New beauveriolides produced by amino acid-supplemented fermentation of Beauveria sp. FO-6979.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

Effect of ACAT inhibition on the progression of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

ACAT inhibitors: the search for a novel and effective treatment of hypercholesterolemia and atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

7 January 2021

Acyl coenzyme A:cholesterol acyltransferase inhibitors as hypolipidemic and antiatherosclerotic drugs

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

7 January 2021

Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

7 January 2021

Verticilide: elucidation of absolute configuration and total synthesis

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

7 January 2021

Beauveriolides, specific inhibitors of lipid droplet formation in mouse macrophages, produced by Beauveria sp. FO-6979.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

7 January 2021

Structure elucidation of fungal beauveriolide III, a novel inhibitor of lipid droplet formation in mouse macrophages

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

7 January 2021

Inhibition of acyl-CoA: cholesterol acyltransferase activity by cyclodepsipeptide antibiotics

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

7 January 2021

New cyclodepsipeptides, enniatins D, E and F produced by Fusarium sp. FO-1305

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

7 January 2021

Pyripyropene A, an acyl-coenzyme A:cholesterol acyltransferase 2-selective inhibitor, attenuates hypercholesterolemia and atherosclerosis in murine models of hyperlipidemia

1 reference

https://api.crossref.org/works/10.1038%2FJA.2012.12

7 January 2021

Identifiers

DOI

10.1038/JA.2012.12

1 reference

11 April 2018

PubMed ID

22415459

1 reference

11 April 2018